肌动蛋白
医学
肌萎缩
物理疗法
心力衰竭
康复
肌生成抑制素
物理医学与康复
生活质量(医疗保健)
有氧运动
手部力量
间歇训练
有氧能力
定时启动测试
最大VO2
焦虑
握力
内科学
等长运动
心率
萧条(经济学)
考试(生物学)
高强度间歇训练
体育锻炼
前瞻性队列研究
力量训练
心脏病学
运动员
心脏病
随机对照试验
无氧运动
作者
Melis Sönmez,Ebru Alemdaroğlu,Ayşe Merve Ata,Habibe Kafes,Berrin İmge Ergüder,Jafar Nouri Nojadeh,Nilüfer Kutay Ordu Gökkaya
出处
期刊:
日期:2026-04-21
卷期号:81 (4): 548-558
被引量:4
标识
DOI:10.1080/00015385.2026.2677223
摘要
Background Cardiac rehabilitation (CR) has been shown to be beneficial in preventing and treating sarcopenia in those with cardiovascular disease. The aim of the study is to compare the effects of high intensity intermittent aerobic training (HIIT) and moderate-intensity continuous aerobic training (MCT) on sarcopenia and myokines in heart failure (HF) patients.Methods In this prospective randomized controlled clinical trial, patients aged 18–75 years with stable HF were enrolled in HIIT or MCT exercise groups 3 days a week for a total of 6 weeks. Before and after treatment, patients were assessed with cardiopulmonary exercise test (CPET), 6-minute walk test (6MWT), modified Medical Research Council scale, short form-36, ultrasonographic thigh muscle thickness measurement, hand grip strength (HGS), chair stand test (CST), hospital anxiety depression scale. Serum myostatin and BDNF levels were also measured.Results In both HIIT and MCT groups, significant improvement was observed on post treatment 6MWT (p = 0.005, p = 0.002), mMRCS (p = 0.005, p = 0.014), quadriceps muscle thickness (p = 0.005, p = 0.001), HGS (p = 0.005, p = 0.001), CST (p = 0.005, p = 0.001) and VO2max (p = 0.022, p = 0.001) compared to before treatment. There was no statistical difference in treatment-related change between the two protocols. The post-treatment myostatin and BDNF levels did not change in both groups (both p > 0.05).Conclusions Both HIIT and MCT exercise training have similar positive effects on sarcopenia, quality of life and functional capacity in patients with HF while having an undetectable effect on biochemical analysis of myostatin and BDNF serum levels. Nonetheless, the absence of detectable changes in circulating myokines should be carefully considered.ClinicalTrials.gov Identifier: NCT07245459.
科研通智能强力驱动
Strongly Powered by AbleSci AI